Disclosing Pleiotropic Effects during Genetic Risk Assessment for Alzheimer’s Disease: A Randomized, Controlled Trial

2016

Background Increasing use of genetic testing raises questions about disclosing secondary findings, including pleiotropic information.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

0

References

1

Citations